Celldex Therapeutics buy Wells Fargo & Company
Start price
20.08.25
/
50%
€18.40
Target price
20.08.26
€32.67
Performance (%)
35.05%
Price
05.06.26
€25.40
Summary
This prediction is currently active. The BUY prediction by Wells_Fargo___Compan for Celldex Therapeutics has seen massive gains of 35.05%. This prediction currently runs until 20.08.26. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Celldex Therapeutics | -5.365% | -5.365% |
| iShares Core DAX® | -1,86 % | 0,67 % |
| iShares Nasdaq 100 | -3,32 % | 4,99 % |
| iShares Nikkei 225® | -2,30 % | 6,13 % |
| iShares S&P 500 | -1,31 % | 3,40 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics (NASDAQ:CLDX) had its price target lowered by analysts at Wells Fargo & Company from $44.00 to $38.00. They now have an "overweight" rating on the stock.
Ratings data for CLDX provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€27.84
13.05.26
13.05.26
€46.01
13.05.27
13.05.27
-10.74%
05.06.26
05.06.26
